U2AF1 and myelodysplastic syndrome: When compared with a cohort of 50 patients with late-onset MDS (≥40 years), U2AF1 mutations were significantly more frequent in patients with young-onset MDS (29% vs. 6%; p = 0.008), whereas other somatic mutations were observed at much lower frequencies (Table 4).